20 years helping business leaders deliver alpha. View our success stories
20 years helping business leaders deliver alpha. View our success stories
By Humatica
Humatica Ltd. was retained to advise the Riverside Company on its investment in Alter Pharma, a Belgian pharmaceutical group. Alter Pharma distributes EU-sourced pharmaceutical products to wholesalers pharmacies and hospitals. It also develops and reformulates generic pharmaceuticals using GMP approved third-party manufacturers, and sells them internationally through partnerships
Humatica provided organisational due diligence services for this transaction.
To view press release: Humatica Advisor to Riverside for AlterPharma
Humatica’s Andros Payne provided expert insights into leveraging organizational effectiveness for value creation at this year’s Private Equity Insights DACH Conference in Munich. Leaders play…
Read more
London, 22 October 2024 – Humatica, the award-winning specialist private equity advisor, has been officially accredited as a Great Place to Work-Certified™ consulting firm again…
Read more
Zurich, 10 July 2024 – Humatica realized unprecedented 89% fee revenue growth in the first half of 2024. Increased professional fees came from both recurring and…
Read more
